OYST
Oyster Point Pharma Inc

817
Loading...
Loading...
Oyster Point Pharma is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of first-in-class pharmaceutical therapies to treat ocular surface diseases. Oyster Point Pharmaâ??s lead product candidate, OC-01, a highly selective nicotinic acetylcholine receptor (nAChR) agonist, is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. Dry eye disease is a chronic, progressive condition that impacts more than 30 million Americans and is growing in prevalence. OC-01â??s novel mechanism of action re-establishes tear film homeostasis by activating the trigeminal parasympathetic pathway to stimulate the glands and cells responsible for natural tear film production, known as the Lacrimal Functional Unit (LFU).
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Oyster Point Pharma Inc?
What is the 52-week high for Oyster Point Pharma Inc?
What is the 52-week low for Oyster Point Pharma Inc?
What is Oyster Point Pharma Inc stock price today?
What was Oyster Point Pharma Inc stock price yesterday?
What is the PE ratio of Oyster Point Pharma Inc?
What is the Price-to-Book ratio of Oyster Point Pharma Inc?
What is the 50-day moving average of Oyster Point Pharma Inc?

Latest OYST News

View
No OYST news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.